137 related articles for article (PubMed ID: 26099427)
21. Prevalence and management of elevated intraocular pressure after placement of an intravitreal sustained-release steroid implant.
Bollinger KE; Smith SD
Curr Opin Ophthalmol; 2009 Mar; 20(2):99-103. PubMed ID: 19248312
[TBL] [Abstract][Full Text] [Related]
22. [Intraocular pressure elevation and intravitreal steroid implant injection: State of the art in 2023. Recommendations of the French Glaucoma Society and French Ophthalmology Society [French version]].
Dot C; Poli M; Aptel F; Labbe A; Kodjikian L; Baillif S; Bodaghi B; Denis P
J Fr Ophtalmol; 2023 Sep; 46(7):803-810. PubMed ID: 37481449
[TBL] [Abstract][Full Text] [Related]
23. Incidence and risk factors for secondary ocular hypertension after intravitreal triamcinolone acetonide injection in Asian Indian eyes.
Mansoori T; Viswanath K; Balakrishna N
Acta Ophthalmol; 2013 Feb; 91(1):e79-80. PubMed ID: 22682374
[No Abstract] [Full Text] [Related]
24. Drug safety evaluation of intravitreal triamcinolone acetonide.
Veritti D; Di Giulio A; Sarao V; Lanzetta P
Expert Opin Drug Saf; 2012 Mar; 11(2):331-40. PubMed ID: 22066820
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
27. Complications of intravitreal steroid injections.
Reichle ML
Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
[TBL] [Abstract][Full Text] [Related]
28. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
[TBL] [Abstract][Full Text] [Related]
29. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature.
Jones R; Rhee DJ
Curr Opin Ophthalmol; 2006 Apr; 17(2):163-7. PubMed ID: 16552251
[TBL] [Abstract][Full Text] [Related]
30. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases.
Jonas JB; Schlichtenbrede F
Eye (Lond); 2008 Jul; 22(7):869-73. PubMed ID: 17304257
[TBL] [Abstract][Full Text] [Related]
31. Uveitis treated with fluocinolone acetonide implants.
Viola F; Staurenghi G; Ratiglia R
Arch Ophthalmol; 2009 Jan; 127(1):115-6; author reply 116. PubMed ID: 19139357
[No Abstract] [Full Text] [Related]
32. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants.
Goldstein DA; Godfrey DG; Hall A; Callanan DG; Jaffe GJ; Pearson PA; Usner DW; Comstock TL
Arch Ophthalmol; 2007 Nov; 125(11):1478-85. PubMed ID: 17923537
[TBL] [Abstract][Full Text] [Related]
33. The effect of intravitreal triamcinolone acetonide on intraocular pressure.
Bakri SJ; Beer PM
Ophthalmic Surg Lasers Imaging; 2003; 34(5):386-90. PubMed ID: 14509462
[TBL] [Abstract][Full Text] [Related]
34. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
Agrawal S; Agrawal J; Agrawal TP
Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
[TBL] [Abstract][Full Text] [Related]
35. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Arcinue CA; Cerón OM; Foster CS
J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal triamcinolone acetonide and intraocular pressure.
Smithen LM; Ober MD; Maranan L; Spaide RF
Am J Ophthalmol; 2004 Nov; 138(5):740-3. PubMed ID: 15531307
[TBL] [Abstract][Full Text] [Related]
37. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
[TBL] [Abstract][Full Text] [Related]
38. Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma.
Robin AL; Suan EP; Sjaarda RN; Callanan DG; Defaller J;
Arch Ophthalmol; 2009 Feb; 127(2):173-8. PubMed ID: 19204235
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effects of intravitreal triamcinolone acetonide and dexamethasone implant in rabbit retinas after pars plana vitrectomy and silicone oil injection.
Siqueira RC; Dos Santos WF; Scott IU; Messias A; Rosa MN; Fernandes Cunha GM; da Silva Cunha A; Jorge R
Retina; 2015 Feb; 35(2):364-70. PubMed ID: 25111686
[TBL] [Abstract][Full Text] [Related]
40. [Not Available].
Leleu I; Penaud B; Blumen-Ohana E; Rodallec T; Adam R; Laplace O; Akesbi J; Nordmann JP
J Fr Ophtalmol; 2018 Oct; 41(8):e329-e340. PubMed ID: 30197188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
